Delivery Order SPE2DB22D1202-SPE2DB25FVHH1
Award Date 8/13/25
Potential Completion Date 8/14/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,155.65 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication commonly used in neurological treatment regimens. This firm fixed price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,161 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mL of Oxcarbazepine 300mg/5mL suspension. As a prime contractor on an indefinite delivery/indefinite quantity pharmaceuticals contract, Amerisourcebergen will deliver the generic anti-seizure medication to a facility in Conshohocken, Pennsylvania by June 27, 2023 to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,025.75, is for the delivery of 4564543492 - Oxcarbazepine 300 mg/5 ml suspension, 250 ml. The contract has an ultimate completion date of May 9, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles, with a ceiling value of $2,874.78 and a period of performance through April 1, 2025. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite...
- The Defense Logistics Agency awarded a $1,257.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 250ml bottles of the pharmaceutical product Oxcarbazepine 300 mg/5 ml suspension. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is three days, from August 18, 2023 through August 21, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count bottles) valued at $5,628.80 under a firm fixed-price contract structure. This non-set-aside delivery order represents a child contract against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was...
- This federal contract award is a firm fixed price delivery order (SPE2DB24FVD24) worth $1,411.99 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The delivery order is for the supply of 4564161306 - OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) awarded by DLA with a potential value of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,629.05 firm fixed-price delivery order is for the supply of 100 units of the medication OXCARBAZEPINE ER 600 MG TABLET. The contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order valued at $237.10 by the Defense Logistics Agency to provide 300mg tablets of Oxcarbazepine in quantities of 100 tablets per unit. The order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania between August 11-14, 2023. No major subcontractors or set aside designations were indicated. This order is part of the Defense Logistics Agency's portfolio of...